title: The choice of dialysate bicarbonate: do different concentrations make a difference?
abstract: Metabolic acidosis is a common complication of chronic kidney disease; it is typically caused by the accumulation of sulfate, phosphorus, and organic anions. Metabolic acidosis is correlated with several adverse outcomes, such as morbidity, hospitalization, and mortality. Thus, correction of metabolic acidosis is fundamental for the adequate management of many systemic complications of chronic kidney disease. In patients undergoing hemodialysis, acid-base homeostasis depends on many factors including the following: net acid production, amount of alkali given by the dialysate bath, duration of the interdialytic period, and residual diuresis, if any. Recent literature data suggest that the development of metabolic alkalosis after dialysis may contribute to adverse clinical outcomes. Our review is focused on the potential effects of different dialysate bicarbonate concentrations on hard outcomes such as mortality. Unfortunately, no randomized studies exist about this issue. Acid-base equilibrium is a complex and vital system whose regulation is impaired in chronic kidney disease. We await further studies to assess the extent to which acid-base status is a major determinant of overall survival in patients undergoing hemodialysis. For the present, the clinician should understand that target values for predialysis serum bicarbonate concentration have been established primarily based on observational studies and expert opinion. Based on this, we should keep the predialysis serum bicarbonate level at least at 22 mmol/l. Furthermore, a specific focus should be addressed by the attending nephrologist to the clinical and nutritional status of the major outliers on both the acid and alkaline sides of the curve.
authors.affiliation: Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy. Electronic address: basile.miulli@libero.it.
authors.forename: Carlo
authors.initials: C
authors.lastname: Basile
authors.affiliation: Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy.
authors.forename: Luigi
authors.initials: L
authors.lastname: Rossi
authors.affiliation: Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy.
authors.forename: Carlo
authors.initials: C
authors.lastname: Lomonte
mesh_terms: D000136:Acid-Base Equilibrium / Q000187:drug effects*; D000138:Acidosis / Q000209:etiology / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control*; D001639:Bicarbonates / Q000008:administration & dosage* / Q000009:adverse effects / Q000592:standards; D015312:Hemodialysis Solutions / Q000008:administration & dosage* / Q000009:adverse effects / Q000592:standards; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008954:Models, Biological; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods* / Q000401:mortality / Q000592:standards; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D001639:Bicarbonates; D015312:Hemodialysis Solutions
keywords: dialysate bicarbonate; hemodialysis; metabolic acidosis; metabolic alkalosis